CiPPPA is a collaborative not-for-profit initiative that connects stakeholders across the entire pharmaceutical supply chain to develop and deploy solutions for recycling of primary pharmaceutical packaging.
The initiative seeks to revolutionise the primary pharmaceutical packaging industry by championing sustainable practices, fostering collaboration and commitment, and developing solutions free from competition, for the benefit of all.
CiPPPA’s Action Task Forces – focusing on blister, inhaler, and injectable packaging – are pivotal in driving the initiative forward. Led by industry experts, their aim is to leverage and optimise existing solutions for pharmaceutical packaging – scaling them for use nationally.
CiPPPA aims to reshape the management of pharmaceutical packaging and lead the healthcare industry in environmental stewardship. Join us in this groundbreaking initiative to contribute to industry-wide transformation.
CiPPPA’s Chairman Duncan Flack, Global Sustainability Lead at Honeywell, is participating in a panel discussion at the upcoming CPHI Middle East event, where he will speak on CiPPPA’s long-term aims and experiences so far. The conference, scheduled from 10-12 December 2024, in Riyadh, Saudi Arabia, is set to be an important gathering for the global pharmaceutical supply chain.
The recent Sustainable Packaging Summit 2024, held in Amsterdam on 12-13 November, was an important platform for industry leaders to showcase their commitment to driving more sustainable solutions. Among the speakers two founding members of CiPPPA, Chiesi and Honeywell, brought their vision to the forefront of this crucial conversation.
In a recent UK parliamentary session, the Circularity in Primary Pharmaceutical Packaging Accelerator (CiPPPA) was highlighted as a key player in the drive towards sustainable healthcare solutions.